GSK Consumers Healthcare gets shareholders' nod for merger with HUL Medical Dialogues Bureau3 Jun 2019 9:30 AM ISTEarlier in January, GlaxoSmithKline (GSK) Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its...
Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 2:39 PM ISTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Cadila Healthcare posts Q4 net profit of Rs 460 crore Medical Dialogues Bureau30 May 2019 9:15 AM ISTThe consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...
Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy Garima29 May 2019 9:45 AM ISTSun Pharma said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of...
Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules Farhat Nasim28 May 2019 10:00 AM ISTThe approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
Natco Pharma Q4 PAT plunges to Rs 120 crore Garima28 May 2019 9:45 AM ISTThe company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25...
Torrent Pharma posts Q4 net loss of Rs 152 crore Garima24 May 2019 9:15 AM ISTThe company had posted a net profit of Rs 228 crore for the corresponding period of the previous fiscal, Torrent Pharma said in a filing to the...
GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore Garima21 May 2019 9:30 AM ISTThe company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal, GSK said in a filing to the BSE.New Delhi:...
Cipla gets no USFDA observations for Indore facility Farhat Nasim18 May 2019 9:45 AM ISTThe US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP Farhat Nasim13 May 2019 10:31 AM ISTZydus Cadila said Chlorthalidone tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug...
GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore Garima11 May 2019 9:35 AM ISTIn a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10...
